Synapse ; 29 : — Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol ; 41 : — Casey KL. Concepts of pain mechanisms: the contribution of functional imaging of the human brain.
Prog Brain Res ; : — Selective opiate modulation of nociceptive processing in the human brain. J Neurophysiol ; 84 : — The role of the basal ganglia in nociception and pain. Pain ; 60 : 3 — Cunningham VJ, Jones T.
Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab ; 13 : 15 — Dennis SG, Melzack R. Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests.
Exp Neurol ; 81 : — Neurology ; 57 : —9. Human brain activity response to fentanyl imaged by positron emission tomography. Anesth Analg ; 82 : — Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp ; 2 : — Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med ; 5 : —5. Opposing effect of apomorphine on antinociceptive activity of morphine: a dose-dependent phenomenon.
Pain ; 36 : —9. Pain ; : 86 — Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse ; 45 : 25 — Happe S, Zeitlhofer J. Abnormal cutaneous thermal thresholds in patients with restless legs syndrome. J Neurol ; : —5. Restless legs syndrome associated with spinal cord lesions. J Neurol Neurosurg Psychiatry ; 66 : —9. The treatment of restless legs syndrome and periodic limb movement disorder.
Sleep ; 22 : — Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology ; 36 : —6. Exp Neurol ; : — Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord ; 10 : 2 —9.
Quantitation of [ 11 C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols. J Neurosci Methods ; 51 : — Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [ 11 C] diprenorphine and positron emission tomography. J Cereb Blood Flow Metab ; 19 : —8. Endogenous opiate response to pain in rheumatoid arthritis and cortical and subcortical response to pain in normal volunteers using positron emission tomography.
Int J Clin Pharmacol Res ; 11 : —6. In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography.
Neurosci Lett ; : 25 —8. Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [ 11 C]diprenorphine binding and PET. Eur J Pain ; 8 : — Analytic 3D image reconstruction using all detected events. Trans Nucl Sci ; 36 : —8. Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord ; 11 : — Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects.
Ann Neurol ; 14 : — Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease?
Mov Disord ; 19 : — Modulation of dopamine release in rat striatal slices by delta opiate agonists. J Pharmacol Exp Ther ; : — Melzack R.
The McGill Pain Questionnaire: major properties and scoring methods. Pain ; 1 : — SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep.
J Neurol ; : — J Neural Transm ; in press. Ondo WG. Methadone for refractory restless legs syndrome. Mov Disord ; in press.
Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. Eur J Pharmacol ; 88 : 27 — Peckys D, Landwehrmeyer GB. Neuroscience ; 88 : — Sensory and motor components of the restless legs syndrome. Neurology ; 42 : —6. Functional imaging of brain responses to pain. A review and meta-analysis Neurophysiol Clin ; 30 : — Opiate receptor binding sites in human brain. Brain Res ; : 87 — Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Ann Neurol ; 42 : —6. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology ; 55 : — Med Prog Technol ; 17 : — Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. Memory and Morbidity in Augsburg Elderly. Neurology ; 54 : —8. Neurology ; 54 : —4. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve ; 19 : —2. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus.
J Rheumatol ; 25 : —5. Neuroreport ; 10 : — Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. Phys Med Biol ; 45 : — Stein C, Mendl G. Pain ; 32 : —5. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome.
Brain ; : — The cortical representation of pain. Pain ; 79 : — Electrophysiological pattern of involuntary limb movements in the restless legs syndrome. Muscle Nerve ; 19 : — Trenkwalder C, Paulus W.
Why do restless legs occur at rest? Pathophysiology of central and peripheral neuronal structures in RLS. Neurophysiology of RLS Part 2. Clin Neurophysiol ; : — Positron emission tomographic studies in restless legs syndrome. Mov Disord ; 14 : —5. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nuclear Medicine Communications ; 25 : 55 — Response to opioids in three patients with restless legs syndrome. Am J Psychiatry ; : —5. Striatal dopaminergic function in restless legs syndrome: [ 18 F]-dopa and [ 11 C]raclopride PET studies.
Neurology ; 52 : —7. Walters AS. Toward a better definition of the restless legs syndrome. Mov Disord ; 10 : — Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med ; 3 : —4.
Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep ; 16 : — Long-term follow-up on restless legs syndrome patients treated with opioids. Approximately 35 percent of subjects who had received the iron treatment still remained off of all RLS medications even 6 months after the treatment. As part of our clinical practice, we will repeat an early-morning, fasting iron panel about 8 weeks after the infusion to establish the new iron status and may repeat another iron panel in about two months to make sure that the iron levels are stable and not dropping.
Several non-drug related treatments that most patients suffering with this disorder already appreciate include hot baths, massaging and rubbing the legs, applying hot or cold packs, restricting the amount of caffeine or alcohol and partaking in moderate physical exercise.
Any of these methods may bring about some level of relief from the symptoms, but in the end, many of these patients will still be unable to have a good night of sleep. To make an appointment with one of our Restless Legs Syndrome physician specialists, please call Request an Appointment. Request your next appointment through My Chart!
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins. Contact us or find a patient care location. Privacy Statement. Non-Discrimination Notice. All rights reserved. Skip Navigation. I Want To I Want to Find Research Faculty Enter the last name, specialty or keyword for your search below. Apply for Admission M.
Center for Restless Legs Syndrome. Patient Resources. Iron Status and Iron Treatment Dr. Christopher Earley discusses the role of iron in the treatment of RLS. Augmentation Dr. Request an Appointment Maryland Patients To make an appointment with one of our Restless Legs Syndrome physician specialists, please call Already a Patient? Traveling for Care? One of these — the mu opioid receptor — is the target of the opioid medications, such as methadone, that are a very effective treatment for severe RLS when used in low total daily doses.
RLS is a neurological disease that has a distinctly different underlying neuropathology than that associated with typical pain syndromes. With this information, they hope to determine if specific opioid medications could selectively act on these mu opioid receptors, reducing the risk of unwanted side effects.
The two-year project is part of broader research to establish the long-term safety and effectiveness of opioids for treating the disease. In the study, Dr. The team will collect data on opiate medication and dose, severity of RLS symptoms, opiate side effects, sleep quality and augmentation.
0コメント